BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33330057)

  • 21. Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling.
    Lu Q; Nie R; Luo J; Wang X; You L
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction and validation of a prognosis signature based on the immune microenvironment in gastric cancer.
    Wu LH; Wang XX; Wang Y; Wei J; Liang ZR; Yan X; Wang J
    Front Surg; 2023; 10():1088292. PubMed ID: 37066015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 9-Gene Signature Correlated With CD8
    Yan K; Lu Y; Yan Z; Wang Y
    Front Immunol; 2021; 12():622563. PubMed ID: 34220795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma.
    Liu S; Geng R; Lin E; Zhao P; Chen Y
    Front Genet; 2021; 12():602160. PubMed ID: 33732282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature.
    Yang Y; Long X; Li G; Yu X; Liu Y; Li K; Tian X
    Bioengineered; 2021 Dec; 12(1):1803-1812. PubMed ID: 34047683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
    Lin J; Lin Y; Huang Z; Li X
    Comput Math Methods Med; 2020; 2020():8836493. PubMed ID: 33273963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single sample scoring of hepatocellular carcinoma: A study based on data mining.
    Zhu D; Wu ZH; Xu L; Yang DL
    Int J Immunopathol Pharmacol; 2021; 35():20587384211018389. PubMed ID: 34053310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
    Kang K; Xie F; Mao J; Bai Y; Wang X
    Front Oncol; 2020; 10():573141. PubMed ID: 33072607
    [No Abstract]   [Full Text] [Related]  

  • 29. Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling.
    Wei Y; Ou T; Lu Y; Wu G; Long Y; Pan X; Yao D
    PeerJ; 2020; 8():e10414. PubMed ID: 33282564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and verification of a 7-lncRNA prognostic model based on tumor immunity for patients with ovarian cancer.
    Feng J; Yu Y; Yin W; Qian S
    J Ovarian Res; 2023 Feb; 16(1):31. PubMed ID: 36739404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature.
    Zhang S; Lv M; Cheng Y; Wang S; Li C; Qu X
    BMC Cancer; 2021 Dec; 21(1):1324. PubMed ID: 34893046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
    Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
    Front Surg; 2022; 9():860806. PubMed ID: 35937602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of cutaneous melanoma.
    Yang S; Liu T; Nan H; Wang Y; Chen H; Zhang X; Zhang Y; Shen B; Qian P; Xu S; Sui J; Liang G
    J Cell Physiol; 2020 Feb; 235(2):1025-1035. PubMed ID: 31240705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune-related risk score: An immune-cell-pair-based prognostic model for cutaneous melanoma.
    Li M; Long X; Bu W; Zhang G; Deng G; Liu Y; Su J; Huang K
    Front Immunol; 2023; 14():1112181. PubMed ID: 36875110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
    Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
    Front Genet; 2022; 13():1053263. PubMed ID: 36712869
    [No Abstract]   [Full Text] [Related]  

  • 39. A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment.
    Gao J; Tang T; Zhang B; Li G
    Front Oncol; 2021; 11():603634. PubMed ID: 33718151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors.
    Li S; Gao J; Xu Q; Zhang X; Huang M; Dai X; Huang K; Liu L
    Front Immunol; 2021; 12():693314. PubMed ID: 34177954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.